Insufficient scRNA-seq data for expression of SUV39H1 at single-cell level.
Insufficient scRNA-seq data for expression of SUV39H1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 502.72 | 1805 / 1809 | 100% | 16.72 | 472 / 472 |
brain | 100% | 437.29 | 2638 / 2642 | 100% | 13.82 | 704 / 705 |
uterus | 100% | 393.33 | 170 / 170 | 99% | 23.66 | 456 / 459 |
breast | 100% | 415.53 | 459 / 459 | 99% | 14.03 | 1110 / 1118 |
bladder | 100% | 389.14 | 21 / 21 | 99% | 16.89 | 500 / 504 |
liver | 100% | 414.08 | 226 / 226 | 99% | 13.00 | 402 / 406 |
prostate | 100% | 385.04 | 245 / 245 | 99% | 7.41 | 497 / 502 |
intestine | 100% | 387.07 | 963 / 966 | 99% | 17.94 | 523 / 527 |
ovary | 99% | 376.96 | 178 / 180 | 100% | 14.73 | 429 / 430 |
esophagus | 100% | 404.54 | 1441 / 1445 | 99% | 14.19 | 181 / 183 |
stomach | 99% | 327.51 | 355 / 359 | 99% | 16.12 | 283 / 286 |
thymus | 100% | 328.56 | 652 / 653 | 97% | 8.47 | 588 / 605 |
lung | 97% | 317.60 | 562 / 578 | 99% | 12.95 | 1147 / 1155 |
adrenal gland | 99% | 243.56 | 256 / 258 | 97% | 9.82 | 223 / 230 |
kidney | 100% | 279.03 | 89 / 89 | 93% | 6.98 | 842 / 901 |
pancreas | 96% | 189.75 | 316 / 328 | 96% | 8.16 | 171 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 10.51 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 32.01 | 29 / 29 |
spleen | 100% | 709.42 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 26.69 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.54 | 1 / 1 |
adipose | 100% | 396.59 | 1199 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 306.67 | 799 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 319.57 | 1328 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 253.55 | 834 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 503.64 | 889 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0097009 | Biological process | energy homeostasis |
GO_0042149 | Biological process | cellular response to glucose starvation |
GO_0045786 | Biological process | negative regulation of cell cycle |
GO_0032259 | Biological process | methylation |
GO_0000183 | Biological process | rDNA heterochromatin formation |
GO_0006974 | Biological process | DNA damage response |
GO_0046015 | Biological process | regulation of transcription by glucose |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0007623 | Biological process | circadian rhythm |
GO_0030154 | Biological process | cell differentiation |
GO_0006364 | Biological process | rRNA processing |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0044725 | Biological process | epigenetic programming in the zygotic pronuclei |
GO_0000775 | Cellular component | chromosome, centromeric region |
GO_0005730 | Cellular component | nucleolus |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0061773 | Cellular component | eNoSc complex |
GO_0000792 | Cellular component | heterochromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005677 | Cellular component | chromatin silencing complex |
GO_0005652 | Cellular component | nuclear lamina |
GO_0033553 | Cellular component | rDNA heterochromatin |
GO_0000794 | Cellular component | condensed nuclear chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0140949 | Molecular function | histone H3K9 trimethyltransferase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0046974 | Molecular function | histone H3K9 methyltransferase activity |
GO_0042054 | Molecular function | histone methyltransferase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0140938 | Molecular function | histone H3 methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008757 | Molecular function | S-adenosylmethionine-dependent methyltransferase activity |
Gene name | SUV39H1 |
Protein name | Histone-lysine N-methyltransferase SUV39H1 (EC 2.1.1.355) (Histone H3-K9 methyltransferase 1) (H3-K9-HMTase 1) (Lysine N-methyltransferase 1A) (Position-effect variegation 3-9 homolog) (Suppressor of variegation 3-9 homolog 1) (Su(var)3-9 homolog 1) |
Synonyms | KMT1A SUV39H |
Description | FUNCTION: Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3 using monomethylated H3 'Lys-9' as substrate. Also weakly methylates histone H1 (in vitro). H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in heterochromatin regions, thereby playing a central role in the establishment of constitutive heterochromatin at pericentric and telomere regions. H3 'Lys-9' trimethylation is also required to direct DNA methylation at pericentric repeats. SUV39H1 is targeted to histone H3 via its interaction with RB1 and is involved in many processes, such as repression of MYOD1-stimulated differentiation, regulation of the control switch for exiting the cell cycle and entering differentiation, repression by the PML-RARA fusion protein, BMP-induced repression, repression of switch recombination to IgA and regulation of telomere length. Component of the eNoSC (energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellular energy status and acts by recruiting histone-modifying enzymes. The eNoSC complex is able to sense the energy status of cell: upon glucose starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA locus. Recruited by the large PER complex to the E-box elements of the circadian target genes such as PER2 itself or PER1, contributes to the conversion of local chromatin to a heterochromatin-like repressive state through H3 'Lys-9' trimethylation. .; FUNCTION: (Microbial infection) Plays a role in defense against mycobacterial infections. Methylates M.tuberculosis HupB on 'Lys-140', probably methylates HupB of M.bovis also. Methylation has an inhibitory effect on mycobacterial growth in the host. Macrophages expressing about 60% SUV39H1 are slightly more susceptible to M.bovis or M.tuberculosis infection. Chaetocin (an inhibitor of this enzyme) increases macrophage survival of M.tuberculosis. This protein inhibits biofilm formation by M.tuberculosis via 'Lys-140' trimethylation. . |
Accessions | ENST00000337852.10 [O43463-2] O43463 ENST00000376687.4 [O43463-1] |